Health Alzheimer's Disease study plans to study 2,000 volunteers' brain scans and blood work to identify biomarkers of ...

Nearly one thousand people attended the Lexington Walk to End Alzheimer's in support of finding a cure for the disease.

A recent study suggests that a drug approved for the treatment of seizures may also help treat Alzheimer's in people who do ...

Neurophet, an artificial intelligence (AI) solution company for brain disease, hosted Neurophet Symposium with Professor ...

Within Tibetan medicine, the medicinal herb Terminalia chebula (T. chebula) is well-known for its extensive therapeutic ...

Alzheimer's disease might damage the brain in two distinct phases, a new study suggests. An early phase that occurs slowly ...

A research team at the Institute of Neurosciences of the University of Barcelona (UBneuro) has led a study describing a new ...

Tallulah Moon, 5, has SPG56, a degenerative brain disease that is caused by a rare gene mutation. Now, the family is selling ...

Rensselaer Polytechnic Institute (RPI) has been awarded two grants by the National Institute on Aging (NIA) to train graduate ...

An analysis of the genetic activity of brain cells in individuals who have died with Alzheimer's disease has revealed the ...

While Alzheimer’s disease (AD) has no cure, five prescription medicines have been approved by the U.S. Food and Drug Administration (FDA) to treat disease symptoms that impact thinking and memory.

By obtaining high-resolution images of Alzheimer’s disease-affected brain cells as the condition progresses, researchers have identified the specific neurons that are damaged. The information the ...